MATTOON, Ill., May 04, 2017 -- First Mid-Illinois Bancshares, Inc. (NASDAQ:FMBH) (the “Company”) announced that on April 26, 2017 its Board of Directors declared a semi-annual dividend of $0.32 per share. The dividend is payable on June 8, 2017 to shareholders of record on June 1, 2017.
About First Mid-Illinois Bancshares, Inc.
First Mid-Illinois Bancshares, Inc. is a financial holding company with over $2.8 billion in assets. Through its subsidiaries, the Company provides a full range of commercial and consumer banking products and services, trust and wealth management, and insurance. First Mid-Illinois Bank & Trust, N.A. (“First Mid Bank”) is a wholly owned bank subsidiary that was first chartered in 1865. First Mid Bank is a community-focused organization that provides financial services through a network of 52 banking centers in 37 Illinois and Missouri communities. More information about the Company is available on our website at www.firstmid.com.
Investor Contact: Aaron Holt VP, Shareholder Relations 217-258-0463 [email protected]


Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes
Netflix Stock Slips After Earnings as Soft 2026 Guidance Overshadows Subscriber Milestone
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit
Microsoft Restores Microsoft 365 Services After Widespread Outage
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 



